Literature DB >> 24735159

2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.

Craig W Lindsley.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24735159      PMCID： PMC3990946          DOI： 10.1021/cn500063v

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN： 1948-7193            Impact factor:   4.418


× No keyword cloud information.
  4 in total

1.  The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2010-06-16       Impact factor: 4.418

2.  The top prescription drugs of 2010 in the United States: antipsychotics show strong growth.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2011-06-15       Impact factor: 4.418

3.  The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-06-19       Impact factor: 4.418

4.  The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418
  4 in total
  2 in total

Review 1.  Targeting the N terminus for site-selective protein modification.

Authors:  Christian B Rosen; Matthew B Francis
Journal:  Nat Chem Biol       Date:  2017-06-20       Impact factor: 15.040

Review 2.  ABC of prescribing exercise as medicine: a narrative review of the experiences of general practitioners and patients.

Authors:  Andrew O'Regan; Michael Pollock; Saskia D'Sa; Vikram Niranjan
Journal:  BMJ Open Sport Exerc Med       Date:  2021-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.